Related Experiment Videos
Post-axial limb defects with maternal sodium valproate exposure
Clinical Dysmorphology
|May 29, 2000
Insights
Intrauterine valproate exposure may cause limb defects. This case study suggests a link between maternal sodium valproate use during pregnancy and postaxial limb abnormalities in male infants.
Area of Science:
- Medical Genetics
- Teratology
- Pediatric Orthopedics
Background:
- Valproate (VPA) is a widely used antiepileptic and mood-stabilizing drug.
- Maternal VPA use during pregnancy is associated with an increased risk of congenital malformations.
- Specific VPA-associated birth defects include neural tube defects and facial clefts.
Observation:
- A male infant presented with bilateral talipes equinovarus (clubfoot).
- The infant also exhibited absent fibulae, tibial bowing, and shortening.
- Facial dysmorphic features were noted in the affected child.
Findings:
- The infant's mother reported daily use of 2000 mg sodium valproate for seizure control during pregnancy.
- This case suggests a potential association between intrauterine VPA exposure and postaxial limb defects.
- The observed limb malformations align with patterns seen in valproate embryopathy.
Implications:
- Highlights the need for careful risk-benefit assessment of valproate use in pregnant women.
- Suggests further research into the teratogenic mechanisms of valproate on limb development.
- Emphasizes the importance of prenatal counseling regarding potential fetal risks associated with maternal antiepileptic drug use.
Abstract:
A male child is described with bilateral talipes equinovarus, absent fibulae with bowing and shortening of the tibiae and facial dysmorphic features. His mother was on a daily dose of 2000 mg sodium valproate for convulsions. This case raises the possibility that postaxial limb defects might be caused by intrauterine valproate exposure.